IP Library Patent Application 13920662
Patent Application
App. No. 13/920,662

Methods and Compositions for Targeting Heterologous Integral Membrane Proteins to the Cyanobacterial Plasma Membrane

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
13/920,662
Abstract

This disclosure pertains to the functional localization of heterologous integral plasma membrane proteins (HIPMPs) lacking cleavable signal sequences into the plasma membrane (PM) of cyanobacterial hosts, e.g., JCC138 ( Synechococcus sp. PCC 7002) or an engineered derivative thereof. More specifically, the disclosure provides chimeric integral plasma membrane proteins comprising pseudo leader sequences (PLSs) that promote increased hydrocarbon (e.g., alkane) export capabilities when expressed in a photosynthetic organism, e.g., a cyanobacterium.

Claims (21)

1 . A method for modifying a heterologous integral plasma membrane protein (HIPMP) to improve its functionality in a target cyanobacterial cell, wherein said method comprises:

(i) fusing a pseudo leader sequence (PLS) to the N-terminus of said HIPMP, wherein said HIPMP has, in its native state, its N-terminus within the cytoplasm, and wherein said PLS consists of two transmembrane alpha helices and a single periplasmic loop sequence linking the two transmembrane alpha helices; or

(ii) adding a PLS to the N-terminus of said HIPMP, wherein said HIPMP has, in its native state, its N-terminus within the periplasm, and wherein said PLS consists of a single transmembrane alpha helix.

2 . The method of claim 1 , wherein said PLS consists of two transmembrane alpha helices and a single periplasmic loop sequence linking the two transmembrane alpha helices, and wherein said PLS is at least 90% identical to a pair of transmembrane alpha helices of an integral plasma membrane protein (IPMP) native to a non-target cyanobacterial species, wherein said IPMP and said pair of transmembrane alpha helices each has, in its native state, its N-terminus within the cytoplasm and its C-terminus within the cytoplasm.

3 . The method of claim 1 , wherein said PLS consists of a single transmembrane alpha helix that is at least 90% identical to a second transmembrane alpha helix of an IPMP native to a non-target cyanobacterial species, wherein said IPMP and said second transmembrane alpha helix each has, in its native state, its N-terminus within the cytoplasm and its C-terminus within the periplasm.

4 . A chimeric integral plasma membrane protein (CIPMP) for facilitating hydrocarbon efflux by a target photosynthetic microorganism, wherein said CIPMP comprises, at its N-terminus, a pseudo leader sequence, wherein said pseudo leader sequence is covalently fused to a heterologous integral plasma membrane protein (IPMP), and wherein said pseudo leader sequence comprises at least one but no more than two transmembrane alpha helices, and wherein the N-terminus of said CIPMP is in the cytoplasm when expressed in said target photosynthetic microorganism.

5 . The CIPMP of claim 4 , wherein said pseudo leader sequence is identical or homologous to one or two transmembrane alpha helices from a non-target bacterial IPMP.

6 . The chimeric protein of claim 5 , wherein said IPMP is at least 90% identical to a non-cyanobacterial IPMP and wherein said pseudo leader sequence is at least 90% identical to a non-target cyanobacterial integral IPMP.

7 . The chimeric protein of claim 4 , wherein the IPMP, in its native state, has its N-terminus in the cytoplasm, and wherein the pseudo leader sequence comprises two transmembrane alpha helices and a periplasmic loop.

8 . The chimeric protein of claim 4 , wherein the IPMP, it its native state, has its N-terminus in the periplasm, and wherein the pseudo leader sequence comprises a single transmembrane alpha helix.

9 . The chimeric protein of claim 8 , wherein said IPMP is a non-cyanobacterial integral plasma membrane protein native to Escherichia coli.

10 . The chimeric protein of claim 9 , wherein said IPMP is a non-cyanobacterial integral plasma membrane protein native to Escherichia coli.

11 . The chimeric protein of claim 9 wherein said non-cyanobacterial integral plasma membrane protein is selected from the group consisting of YbhR and YbhS.

12 . The chimeric protein of claim 10 wherein said non-cyanobacterial integral plasma membrane protein is selected from the group consisting of YbhR and YbhS.

13 . A recombinant nucleic acid encoding the CIPMP of claim 4 .

14 . A vector comprising a promoter operatively linked to a nucleic acid encoding any of the proteins of claim 4 .

15 . An engineered photosynthetic microorganism comprising the CIPMP of claim 4 .

16 . The engineered photosynthetic microorganism of claim 15 , further comprising one or more recombinant genes encoding an acyl-ACP reductase enzyme, an alkanal deformylative monooxygenase enzyme, or both enzymes.

17 . A method for producing a hydrocarbon, comprising

(i) culturing an engineered photosynthetic microorganism of claim 15 in a culture medium; and

(ii) exposing said engineered photosynthetic microorganism to light and inorganic carbon, wherein said exposure results in the conversion of said carbon dioxide by said engineered photosynthetic microorganism into n-alkanes, wherein said n-alkanes are effluxed into said culture medium in an amount greater than that secreted by an otherwise identical photosynthetic microorganism, cultured under identical conditions, but lacking any of the CIPMP of claim 4 .

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 9, 2014
From: REPPAS, NIKOS BASIL
To: JOULE UNLIMITED TECHNOLOGIES, INC.
Reel/Frame 033271/0992 →